4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Annexon, Inc. (ANNX) operates in the Biotechnology industry and is headquartered in Brisbane, United States with about 93 employees. Its market capitalization is roughly $855 million. In the fiscal year ended 2025-12-31, ANNX reported $0M in revenue and ($207M) in net income.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($216M) | ($154M) | ($144M) | ($146M) | — |
| Net Income | ($207M) | ($138M) | ($134M) | ($142M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($46M) | ($50M) | ($57M) | ($52M) | ($57M) |
| Net Income | ($44M) | ($48M) | ($55M) | ($49M) | ($54M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $278M | $350M | $298M | $285M | — |
| Total Liabilities | $66M | $57M | $47M | $54M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANNX viewer.
About TickerBase · Data methodology & sources